Lifecore Biomedical, Inc. De (LFCR) Net Cash Flow (2010 - 2025)

Lifecore Biomedical has reported Net Cash Flow for 16 years, with the latest figure at -$1.2 million in Q2 2025.

• On a quarterly basis, Net Cash Flow fell 122.08% year-over-year to -$1.2 million in Q2 2025; TTM through May 2025 was -$4.2 million, a 60.14% increase from a year earlier, with the FY2025 full-year figure at -$197000.0, up 98.15% from the prior year.
• Net Cash Flow was -$1.2 million for Q2 2025 at Lifecore Biomedical, up from -$4.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $16.1 million in Q2 2023, with the low at -$10.4 million in Q3 2023.
• Average Net Cash Flow over 5 years is $96333.3, with a median of -$227000.0 recorded in 2021.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 7749.76% in 2023, then sank 2629.73% in 2025.
• Over 5 years, Net Cash Flow stood at -$356000.0 in 2021, then surged by 832.58% to $2.6 million in 2022, then sank by 307.86% to -$5.4 million in 2023, then surged by 172.59% to $3.9 million in 2024, then sank by 130.24% to -$1.2 million in 2025.
• The last three Net Cash Flow figures came in at -$1.2 million (Q2 2025), -$4.0 million (Q1 2025), and $3.9 million (Q4 2024), per Business Quant data.